Phlebotomy, blood donation, and hereditary hemochromatosis

Transfusion Medicine Reviews

Volumn 15, Issue 2, 2001, Pages 136-143

  Conry Cantilena, Cathy ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; CLINICAL FEATURE; CLINICAL PROTOCOL; FOOD AND DRUG ADMINISTRATION; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; PATIENT; PHLEBOTOMY; REVIEW; SAFETY; UNITED STATES;

EID: 0035051525     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tm.2001.22616     Document Type: Review

References (35)

1. Celtic origin of the C282Y mutation of hemochromatosis
2. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis
3. Diagnosis of Hemochromatosis
4. Epidemiology, clinical spectrum, and prognosis of hemochromatosis
5. Hemochromatosis in the new millennium
6. Management of hemochromatosis
7. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis
8. Screening for hemochromatosis
9. Diagnosis and treatment of iron overload in the practice of hematology
10. Hemochromatosis: Association of severity of iron overload with genetic markers
11. Value of the mean corpuscular volume as a guide to phlebotomy therapy in genetic hemochromatosis
12. Effect of non-monetary incentives on safety of blood donations
13. The risk of transfusion transmitted viral infections
14. Estimates of infections disease risk factors in US blood donors
15. Paid-vs-volunteer blood donation in the United States: A historical review
16. Concurrent comparison of the safety of paid cytapheresis and volunteer whole-blood donors
17. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland
18. Donating blood is associated with reduced risk of myocardial infarction: The Kuopio Ischemic Heart Disease risk factor study (KIHD)
19. A survey of phlebotomy among persons with hemochromatosis
20. A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment
21. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis
22. Incidence of liver disease in people with HFE mutations
23. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA
24. Mild liver enzyme abnormalities: Eliminating hemochromatosis as a cause
25. Multiple liver abscesses due to Yersinia enterocolitica disclose primary hemochromatosis: Three cases and a review
26. Bacterial infections in hemochromatosis
27. Hemochromatosis probands as blood donors
28. Strategies to increase detection of hemochromatosis
29. Iron overload, public health and genetics: Evaluating the evidence for hemochromatosis screening
30. A postulation based study of the clinical expression of the hemochromatosis gene
31. Prevalence of elevated serum transferrin saturation in adults in the United States
32. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis